Product
C1K
Aliases
C1K 1200mg, C1K 150mg, C1K 300mg, C1K 600mg, C1K 900mg
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Dose-block Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose, First-in-human, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-06-28